Hot Features
プレミアム
Agios Pharmaceuticals Inc (AGIO)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Mr. James William BurnsChief Legal Officer | 5.22k | 0.00 | Derivative Exercise and Retained Stock | - | 49.31k | 11.84% |
| 2026-04-02 | Mr. James William BurnsChief Legal Officer | -3.28k | 113.85k | Derivative Exercise and Sale | 34.71 | 49.31k | - |
| 2026-04-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2.94k | 102.05k | Derivative Exercise and Sale | 34.71 | 80.28k | - |
| 2026-04-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 5.56k | 0.00 | Derivative Exercise and Retained Stock | - | 80.28k | 7.44% |
| 2026-04-02 | Ms. Cecilia JonesCFO | -3.14k | 109.02k | Derivative Exercise and Sale | 34.71 | 55.00k | - |
| 2026-04-02 | Ms. Cecilia JonesCFO | 5.36k | 0.00 | Derivative Exercise and Retained Stock | - | 55.00k | 10.80% |
| 2026-04-02 | Ms. Tsveta MilanovaChief Commercial Officer | -3.26k | 113.22k | Derivative Exercise and Sale | 34.71 | 46.83k | - |
| 2026-04-02 | Ms. Tsveta MilanovaChief Commercial Officer | 5.24k | 0.00 | Derivative Exercise and Retained Stock | - | 46.83k | 12.59% |
| 2026-04-02 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | -2.96k | 102.71k | Derivative Exercise and Sale | 34.71 | 10.28k | - |
| 2026-04-02 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | 5.14k | 0.00 | Derivative Exercise and Retained Stock | - | 10.28k | 100.00% |
| 2026-04-02 | Mr. Brian M. GoffCEO & Director | -19.07k | 661.85k | Derivative Exercise and Sale | 34.71 | 184.51k | - |
| 2026-04-02 | Mr. Brian M. GoffCEO & Director | 19.96k | 0.00 | Derivative Exercise and Retained Stock | - | 184.51k | 12.13% |
| 2026-03-05 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | 5.14k | 0.00 | Derivative Exercise and Retained Stock | - | 5.14k | - |
| 2026-03-05 | Dr. Krishnan ViswanadhanChief Strategy & Operations Officer | -2.96k | 82.26k | Derivative Exercise and Sale | 27.80 | 5.14k | - |
| 2026-03-03 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -5.27k | 152.26k | 売り | 28.88 | 868.00 | -85.86% |
| 2026-03-02 | Mr. Brian M. GoffCEO & Director | 21.45k | 0.00 | Derivative Exercise and Retained Stock | - | 164.55k | 14.99% |
| 2026-03-02 | Mr. Brian M. GoffCEO & Director | -18.06k | 522.87k | Derivative Exercise and Sale | 28.96 | 164.55k | - |
| 2026-03-02 | Mr. James William BurnsChief Legal Officer | 12.37k | 0.00 | Derivative Exercise and Retained Stock | - | 44.09k | 38.99% |
| 2026-03-02 | Mr. James William BurnsChief Legal Officer | -5.22k | 151.11k | Derivative Exercise and Sale | 28.96 | 44.09k | - |
| 2026-03-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 9.61k | 0.00 | Derivative Exercise and Retained Stock | - | 74.41k | 14.83% |
| 2026-03-02 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -4.06k | 117.43k | Derivative Exercise and Sale | 28.96 | 74.41k | - |
| 2026-03-02 | Ms. Cecilia JonesCFO | 11.93k | 0.00 | Derivative Exercise and Retained Stock | - | 49.33k | 31.91% |
| 2026-03-02 | Ms. Cecilia JonesCFO | -5.04k | 145.81k | Derivative Exercise and Sale | 28.96 | 49.33k | - |
| 2026-03-02 | Ms. Tsveta MilanovaChief Commercial Officer | 6.80k | 0.00 | Derivative Exercise and Retained Stock | - | 41.59k | 19.54% |
| 2026-03-02 | Ms. Tsveta MilanovaChief Commercial Officer | -2.87k | 83.06k | Derivative Exercise and Sale | 28.96 | 41.59k | - |
| 2026-03-02 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | 5.27k | 0.00 | Derivative Exercise and Retained Stock | - | 6.14k | 607.37% |
| 2026-03-02 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -2.22k | 64.38k | Derivative Exercise and Sale | 28.96 | 6.14k | - |
| 2026-01-05 | Ms. Tsveta MilanovaChief Commercial Officer | 5.60k | 0.00 | Derivative Exercise and Retained Stock | - | 34.79k | 19.19% |
| 2026-01-05 | Ms. Tsveta MilanovaChief Commercial Officer | -2.87k | 77.60k | Derivative Exercise and Sale | 27.02 | 34.79k | - |
| 2025-12-30 | Mr. James William BurnsChief Legal Officer | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 31.72k | 10.71% |
| 2025-12-30 | Mr. James William BurnsChief Legal Officer | -2.93k | 79.43k | Derivative Exercise and Sale | 27.09 | 31.72k | - |
| 2025-12-30 | Mr. Brian M. GoffCEO & Director | 19.58k | 0.00 | Derivative Exercise and Retained Stock | - | 143.10k | 15.85% |
| 2025-12-30 | Mr. Brian M. GoffCEO & Director | -18.70k | 506.66k | Derivative Exercise and Sale | 27.09 | 143.10k | - |
| 2025-12-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 64.80k | 4.97% |
| 2025-12-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2.93k | 79.43k | Derivative Exercise and Sale | 27.09 | 64.80k | - |
| 2025-12-30 | Ms. Tsveta MilanovaChief Commercial Officer | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 29.19k | 11.74% |
| 2025-12-30 | Ms. Tsveta MilanovaChief Commercial Officer | -2.93k | 79.43k | Derivative Exercise and Sale | 27.09 | 29.19k | - |
| 2025-12-30 | Ms. Cecilia JonesCFO | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 37.39k | 8.94% |
| 2025-12-30 | Ms. Cecilia JonesCFO | -2.93k | 79.43k | Derivative Exercise and Sale | 27.09 | 37.39k | - |
| 2025-11-12 | Dr. David T. ScaddenIndependent Director | -200.00 | 5.15k | Derivative Exercise and Sale | 18.09 - 43.84 | 17.60k | - |
| 2025-11-11 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2.45k | 46.06k | Derivative Exercise and Sale | 25.01 - 43.78 | 61.73k | - |
| 2025-10-30 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -200.00 | 3.76k | Derivative Exercise and Sale | 25.01 - 43.81 | 61.73k | - |
| 2025-10-27 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -3.30k | 62.44k | Derivative Exercise and Sale | 25.01 - 43.92 | 61.73k | - |
| 2025-10-08 | Dr. David T. ScaddenIndependent Director | -200.00 | 4.58k | Derivative Exercise and Sale | 18.09 - 41.00 | 17.60k | - |
| 2025-09-30 | Dr. David T. ScaddenIndependent Director | -200.00 | 4.38k | Derivative Exercise and Sale | 18.09 - 40.00 | 17.60k | - |
| 2025-09-26 | Ms. Cecilia JonesCFO | 3.82k | 0.00 | Derivative Exercise and Retained Stock | - | 33.87k | 12.72% |
| 2025-09-26 | Ms. Cecilia JonesCFO | -3.65k | 134.25k | Derivative Exercise and Sale | 36.77 | 33.87k | - |
| 2025-09-05 | Mr. T. J. WashburnVP, Controller & Principal Accounting Officer | -8.55k | 315.09k | 売り | 36.87 | 868.00 | -90.78% |
| 2025-08-27 | Dr. David T. ScaddenIndependent Director | -200.00 | 4.38k | Derivative Exercise and Sale | 18.09 - 40.00 | 17.60k | - |
| 2025-08-11 | Dr. Rahul D. BallalIndependent Director | 2.30k | 0.00 | Derivative Exercise and Retained Stock | - | 12.41k | 22.77% |
| 2025-08-11 | Ms. Cynthia SmithIndependent Director | 2.30k | 0.00 | Derivative Exercise and Retained Stock | - | 12.41k | 22.77% |
| 2025-08-08 | Mr. Brian M. GoffCEO & Director | 11.61k | 0.00 | Derivative Exercise and Retained Stock | - | 123.53k | 10.37% |
| 2025-08-08 | Mr. Brian M. GoffCEO & Director | -11.09k | 406.49k | Derivative Exercise and Sale | 36.67 | 123.53k | - |
| 2025-07-10 | Dr. David T. ScaddenIndependent Director | -1.40k | 30.67k | Derivative Exercise and Sale | 18.09 - 40.00 | 17.60k | - |
| 2025-07-09 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -11.91k | 154.63k | Derivative Exercise and Sale | 25.01 - 38.76 | 61.27k | - |
| 2025-07-01 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 4.28k | 0.00 | Derivative Exercise and Retained Stock | - | 61.27k | 7.52% |
| 2025-07-01 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -4.09k | 139.79k | Derivative Exercise and Sale | 34.17 | 61.27k | - |
| 2025-06-24 | Mr. James William BurnsChief Legal Officer | 3.20k | 0.00 | Derivative Exercise and Retained Stock | - | 28.65k | 12.58% |
| 2025-06-24 | Mr. James William BurnsChief Legal Officer | -2.80k | 93.88k | Derivative Exercise and Sale | 33.54 | 28.65k | - |
| 2025-06-24 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | 3.09k | 0.00 | Derivative Exercise and Retained Stock | - | 56.99k | 5.74% |
| 2025-06-24 | Dr. Sarah GheuensChief Medical Officer and Head of Research & Development | -2.91k | 97.57k | Derivative Exercise and Sale | 33.54 | 56.99k | - |
| 2025-06-24 | Ms. Cecilia JonesCFO | 4.22k | 0.00 | Derivative Exercise and Retained Stock | - | 30.05k | 16.34% |
| 2025-06-24 | Ms. Cecilia JonesCFO | -1.78k | 59.70k | Derivative Exercise and Sale | 33.54 | 30.05k | - |
| 2025-06-24 | Ms. Tsveta MilanovaChief Commercial Officer | 3.23k | 0.00 | Derivative Exercise and Retained Stock | - | 26.12k | 14.11% |
| 2025-06-24 | Ms. Tsveta MilanovaChief Commercial Officer | -2.77k | 92.91k | Derivative Exercise and Sale | 33.54 | 26.12k | - |
| 2025-06-24 | Mr. Brian M. GoffCEO & Director | 19.58k | 0.00 | Derivative Exercise and Retained Stock | - | 111.92k | 21.20% |
| 2025-06-24 | Mr. Brian M. GoffCEO & Director | -18.70k | 627.20k | Derivative Exercise and Sale | 33.54 | 111.92k | - |
| 2025-06-20 | Dr. Rahul D. BallalIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 10.11k | 26.53% |
| 2025-06-20 | Mr. Jeffrey D. CapelloIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 6.07k | 53.63% |
| 2025-06-20 | Ms. Kaye I. Foster-CheekLead Independent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 7.47k | 39.64% |
| 2025-06-20 | Dr. Jacqualyn A. FouseChair of the Board of Directors | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 151.34k | 1.42% |
| 2025-06-20 | Dr. Maykin HoIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 17.03k | 14.22% |
| 2025-06-20 | Ms. Catherine E. Owen AdamsIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 6.07k | 53.63% |
| 2025-06-20 | Dr. David T. ScaddenIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 17.60k | 13.69% |
| 2025-06-20 | Ms. Cynthia SmithIndependent Director | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 10.11k | 26.53% |
| 2025-06-13 | Mr. Jeffrey D. CapelloIndependent Director | 1.98k | 0.00 | Derivative Exercise and Retained Stock | - | 3.95k | 100.05% |
| 2025-06-13 | Ms. Catherine E. Owen AdamsIndependent Director | 1.98k | 0.00 | Derivative Exercise and Retained Stock | - | 3.95k | 100.05% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
